127 related articles for article (PubMed ID: 3621527)
1. Oxypurinol limits myocardial stunning but does not reduce infarct size after reperfusion.
Puett DW; Forman MB; Cates CU; Wilson BH; Hande KR; Friesinger GC; Virmani R
Circulation; 1987 Sep; 76(3):678-86. PubMed ID: 3621527
[TBL] [Abstract][Full Text] [Related]
2. The xanthine oxidase inhibitor oxypurinol does not limit infarct size in a canine model of 40 minutes of ischemia with reperfusion.
Kinsman JM; Murry CE; Richard VJ; Jennings RB; Reimer KA
J Am Coll Cardiol; 1988 Jul; 12(1):209-17. PubMed ID: 3379207
[TBL] [Abstract][Full Text] [Related]
3. Xanthine oxidase inhibition does not limit canine infarct size.
Werns SW; Grum CM; Ventura A; Hahn RA; Ho PP; Towner RD; Fantone JC; Schork MA; Lucchesi BR
Circulation; 1991 Mar; 83(3):995-1005. PubMed ID: 1999047
[TBL] [Abstract][Full Text] [Related]
4. Evidence for a pathogenetic role of xanthine oxidase in the "stunned" myocardium.
Charlat MI; O'Neill PG; Egan JM; Abernethy DR; Michael LH; Myers ML; Roberts R; Bolli R
Am J Physiol; 1987 Mar; 252(3 Pt 2):H566-77. PubMed ID: 3826401
[TBL] [Abstract][Full Text] [Related]
5. Oxypurinol limits myocardial infarct size in closed chest dogs without pretreatment.
Matsuki T; Shirato C; Cohen MV; Downey JM
Can J Cardiol; 1990 Apr; 6(3):123-9. PubMed ID: 2340442
[TBL] [Abstract][Full Text] [Related]
6. Therapy to reduce free radicals during early reperfusion does not limit the size of myocardial infarcts caused by 90 minutes of ischemia in dogs.
Richard VJ; Murry CE; Jennings RB; Reimer KA
Circulation; 1988 Aug; 78(2):473-80. PubMed ID: 3396182
[TBL] [Abstract][Full Text] [Related]
7. A useful canine model of ischemic myocardium with coronary retrograde flow diversion, and its application for the study of allopurinol on myocardial infarct size.
Motoe M; Yoshida S
Jpn Circ J; 1991 May; 55(5):490-9. PubMed ID: 2062000
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effects of oxypurinol pretreatment in stunned, reperfused canine myocardium.
Holzgrefe HH; Gibson JK
Cardiovasc Res; 1989 Apr; 23(4):340-50. PubMed ID: 2590915
[TBL] [Abstract][Full Text] [Related]
9. Glutathione redox pathway and reperfusion injury. Effect of N-acetylcysteine on infarct size and ventricular function.
Forman MB; Puett DW; Cates CU; McCroskey DE; Beckman JK; Greene HL; Virmani R
Circulation; 1988 Jul; 78(1):202-13. PubMed ID: 3383404
[TBL] [Abstract][Full Text] [Related]
10. Salvage of ischaemic myocardium by reperfusion: importance of collateral blood flow and myocardial oxygen demand during occlusion.
Przyklenk K; Vivaldi MT; Schoen FJ; Malcolm J; Arnold O; Kloner RA
Cardiovasc Res; 1986 Jun; 20(6):403-14. PubMed ID: 3779738
[TBL] [Abstract][Full Text] [Related]
11. Role of xanthine oxidase inhibitor as free radical scavenger: a novel mechanism of action of allopurinol and oxypurinol in myocardial salvage.
Das DK; Engelman RM; Clement R; Otani H; Prasad MR; Rao PS
Biochem Biophys Res Commun; 1987 Oct; 148(1):314-9. PubMed ID: 2823807
[TBL] [Abstract][Full Text] [Related]
12. Effect of the platelet-activating factor antagonist RP 59227 (Tulopafant) on myocardial ischemia/reperfusion injury and neutrophil function.
Auchampach JA; Pieper GM; Cavero I; Gross GJ
Basic Res Cardiol; 1998 Oct; 93(5):361-71. PubMed ID: 9833148
[TBL] [Abstract][Full Text] [Related]
13. An anti-CD18 antibody limits infarct size and preserves left ventricular function in dogs with ischemia and 48-hour reperfusion.
Arai M; Lefer DJ; So T; DiPaula A; Aversano T; Becker LC
J Am Coll Cardiol; 1996 Apr; 27(5):1278-85. PubMed ID: 8609356
[TBL] [Abstract][Full Text] [Related]
14. Failure of the xanthine oxidase inhibitor allopurinol to limit infarct size after ischemia and reperfusion in dogs.
Reimer KA; Jennings RB
Circulation; 1985 May; 71(5):1069-75. PubMed ID: 3838707
[TBL] [Abstract][Full Text] [Related]
15. Reduction of the size of infarction by allopurinol in the ischemic-reperfused canine heart.
Werns SW; Shea MJ; Mitsos SE; Dysko RC; Fantone JC; Schork MA; Abrams GD; Pitt B; Lucchesi BR
Circulation; 1986 Mar; 73(3):518-24. PubMed ID: 3004782
[TBL] [Abstract][Full Text] [Related]
16. Cloricromene reduces infarct size and alters postischaemic blood flow defects in dog myocardium.
Groban L; Zvara DA; Deal DD; Vernon JC; Flye CW; Ma XL; Vinten-Johansen J
Clin Exp Pharmacol Physiol; 1998 Jun; 25(6):417-23. PubMed ID: 9673816
[TBL] [Abstract][Full Text] [Related]
17. Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release, and neutrophil function in dogs.
Mizumura T; Nithipatikom K; Gross GJ
Circulation; 1995 Sep; 92(5):1236-45. PubMed ID: 7648671
[TBL] [Abstract][Full Text] [Related]
18. Reduction of reperfusion injury in the canine preparation by intracoronary adenosine: importance of the endothelium and the no-reflow phenomenon.
Olafsson B; Forman MB; Puett DW; Pou A; Cates CU; Friesinger GC; Virmani R
Circulation; 1987 Nov; 76(5):1135-45. PubMed ID: 3664998
[TBL] [Abstract][Full Text] [Related]
19. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs.
Uraizee A; Reimer KA; Murry CE; Jennings RB
Circulation; 1987 Jun; 75(6):1237-48. PubMed ID: 3568330
[TBL] [Abstract][Full Text] [Related]
20. Infarct size limitation by the xanthine oxidase inhibitor, allopurinol, in closed-chest dogs with small infarcts.
Akizuki S; Yoshida S; Chambers DE; Eddy LJ; Parmley LF; Yellon DM; Downey JM
Cardiovasc Res; 1985 Nov; 19(11):686-92. PubMed ID: 3841027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
